Literature DB >> 18269448

Initial experience of functional imaging of upper urinary tract neoplasm by diffusion-weighted magnetic resonance imaging.

Soichiro Yoshida1, Hitoshi Masuda, Chikako Ishii, Kazutaka Saito, Satoru Kawakami, Kazunori Kihara.   

Abstract

OBJECTIVES: Diffusion-weighted (DW) magnetic resonance imaging (MRI) provides functional information widely used in the diagnosis of acute cerebral stroke. We reported our initial experience of this imaging technique of upper urinary tract (UUT) urothelial carcinoma (UC).
METHODS: Diffusion-weighted magnetic resonance imaging was carried out in 10 consecutive patients with suspected UUT UC. With conventional imaging, seven were diagnosed as having renal pelvic tumors and two were highly suspected of having UUT UC. These nine patients were diagnosed histopathologically as having renal pelvic UC by subsequent operation. The last patient was confirmed as experiencing benign stenosis. DW MRI was obtained with a 1.5-T MR imager without a breath-holding sequence. The apparent diffusion coefficient (ADC) values of renal parenchyma, dilated collecting system, and tumor were calculated. The differences were analyzed using Wilcoxon t-test.
RESULTS: On DW MRI, all nine tumors showed hyperintensity with negligible urinary intensity. Two cases of highly suspected UUT UC with unclear conventional MRI had high signal intensity and contrast. The case of benign stenosis had negative DW MRI. The median (range) ADC value of the tumor (0.803 [0.412-0.958] x 10(-3) mm(2)/s) was significantly lower than those of the dilated collecting system (2.19 [1.42-2.40] x 10(-3)) and renal parenchyma (1.28 [0.922-1.45] x 10(-3), respectively (P < 0.01 and P < 0.01).
CONCLUSIONS: This is the first report on the application of DW MRI for a series of UUT UC. With this technique, a clear demonstration of UUT UC could be obtained. Moreover, this imaging technique is potentially useful to identify small lesions if they have a low diffusion coefficient.

Entities:  

Mesh:

Year:  2008        PMID: 18269448     DOI: 10.1111/j.1442-2042.2007.01950.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  6 in total

1.  Oncological and renal outcomes of segmental ureterectomy vs. radical nephroureterectomy for upper tract urothelial carcinoma.

Authors:  Tomonori Kato; Ryo Nakayama; Tomomi Haba; Makoto Kawaguchi; Akira Komiya; Hiroshi Koike
Journal:  Oncol Lett       Date:  2018-09-19       Impact factor: 2.967

2.  Imaging: does DW-MRI have a role in the evaluation of hematuria?

Authors:  David Galvin; Bernard H Bochner
Journal:  Nat Rev Urol       Date:  2009-09       Impact factor: 14.432

3.  Significance of ADC value for detection and characterization of urothelial carcinoma of upper urinary tract using diffusion-weighted MRI.

Authors:  A Sufana Iancu; P Colin; P Puech; A Villers; A Ouzzane; J C Fantoni; X Leroy; L Lemaitre
Journal:  World J Urol       Date:  2012-09-21       Impact factor: 4.226

4.  Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness.

Authors:  Shuichiro Kobayashi; Fumitaka Koga; Soichiro Yoshida; Hitoshi Masuda; Chikako Ishii; Hiroshi Tanaka; Yoshinobu Komai; Minato Yokoyama; Kazutaka Saito; Yasuhisa Fujii; Satoru Kawakami; Kazunori Kihara
Journal:  Eur Radiol       Date:  2011-06-18       Impact factor: 5.315

5.  Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer: a preliminary report.

Authors:  Soichiro Yoshida; Shuichiro Kobayashi; Fumitaka Koga; Junichiro Ishioka; Chikako Ishii; Hiroshi Tanaka; Yasukazu Nakanishi; Yoh Matsuoka; Noboru Numao; Kazutaka Saito; Hitoshi Masuda; Yasuhisa Fujii; Kazunori Kihara
Journal:  Eur Radiol       Date:  2013-03-15       Impact factor: 5.315

6.  Bladder tumour staging: comparison of diffusion- and T2-weighted MR imaging.

Authors:  Ahmed El-Assmy; Mohamed E Abou-El-Ghar; Ahmed Mosbah; Ahmed R El-Nahas; Huda F Refaie; Ihab A Hekal; Tarek El-Diasty; El Housseiny Ibrahiem
Journal:  Eur Radiol       Date:  2009-02-27       Impact factor: 5.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.